| Literature DB >> 29209877 |
Dalila Moter Benvegnú1,2, Katiane Roversi3, Raquel Cristine Silva Barcelos3, Fabíola Trevizol3, Camila Simonetti Pase3, Hecson Jesser Segat4, Verônica Tironi Dias3, Ana Luiza Savian5, Bruna Lopes Piccoli6, Jaqueline Piccolo3, Carlos Severo Dutra-Filho6, Tatiana Emanuelli3, Cristiane de Bona da Silva5, Ruy Carlos Ruver Beck7, Marilise Escobar Burger8,9.
Abstract
Haloperidol is a widely used antipsychotic, despite the severe motor side effects associated with its chronic use. This study was carried out to compare oral dyskinesia induced by different formulations of haloperidol-loaded nanocapsules containing caprylic/capric triglycerides, fish oil or grape seed oil (GSO) as core, as well as free haloperidol. Haloperidol-loaded lipid-core nanocapsules formulations were prepared, physicochemical characterized and administered (0.5 mg kg-1-ip) to rats for 28 days. Oral dyskinesia was evaluated acutely and subchronically and after that cell viability and free radical generation in cortex and substantia nigra. All formulations presented satisfactory physicochemical parameters. Acutely, all formulations were able to prevent oral dyskinesia development in comparison to free haloperidol, except haloperidol-loaded nanocapsules containing GSO, whose effect was only partial. After subchronic treatment, all haloperidol-loaded nanocapsules formulations prevented oral dyskinesia in relation to free drug. Also, haloperidol-loaded nanocapsules containing fish oil and GSO were more effective than caprylic/capric triglycerides nanocapsules and free haloperidol in cell viability preservation and control of free radical generation. Our findings showed that fish oil formulation may be considered as the best formulation of haloperidol-loaded lipid-core nanocapsules, being able to prevent motor side effects associated with chronic use of antipsychotic drugs, as haloperidol.Entities:
Keywords: Cell viability; Fish oil; Free radical generation; Haloperidol; Polymeric lipid-core nanocapsule
Mesh:
Substances:
Year: 2017 PMID: 29209877 DOI: 10.1007/s11064-017-2444-0
Source DB: PubMed Journal: Neurochem Res ISSN: 0364-3190 Impact factor: 3.996